| |
Wednesday,
May 7 |
Thursday,
May 8 |
Friday,
May 9 |
Saturday,
May 10 |
Sunday,
May 11 |
Monday,
May 12 |
| 08:30
- 10:30 |
|
08:00
- 12:00
Registration opens |
AD:
Amyloids,
Presenilin
Hall A
|
PD and Dystonia. Parkin and Torsina
Hall B
|
10:00
- 16:30
Posters |
TAU & Mechanistic Aspects
Hall A
|
Biomarkers,
and Diagnostic Aspects of AD,
and PD (I)
Hall B
|
10:00
- 17:30
Posters |
Animal Models
in AD, PD (I)
Hall A
|
Vascular
Dementia
Hall B
|
10:00
- 17:30
Posters |
Removal of
Amyloid &
Plaques
Hall A
|
Mechanism and Treatment of Motor Fluctuations
in PD
Hall B
|
10:00
- 17:30
Posters |
10:30-
11:00 |
|
|
COFFEE BREAK, EXHIBITION & POSTERS |
| 11:00-
13:00 |
|
|
LMW Glycosamino-glycans as potential Agents
in the Treatment of Neurodegenerative Disorders
Hall A
|
Etiology and Pathogenesis
of PD
Hall B
|
Treatment
and Potential Disease
Modification in AD
Hall A
|
Neuropathological
Aspects in AD, PD, MCI
Hall A
|
Treatment
of PD
Hall B
|
Inflammatory Processes in Neurodegene-
ration
Hall A
|
APOE:
Therapeutic
Relevance in AD
Hall B
|
|
13:00-14:30
|
|
12:30-13:40
Opening Ceremony
Hall A
|
Meet the Experts:
Galantamine Across the Spectrum of Dementia
Sponsored by Janssen-Cilag
Carmona Hall
|
Lunch Break
|
Lunch Satellite Symposium:
The Importance of DaT in the
Diagnosis and Progression of PS
Sponsored by Amersham Health
Hall A
|
Lunch Satellite Symposium:
NMDA Protection:
New Alzheimer Therapy
and Patients Benefit
Sponsored by Merz Pharmaceuticals GmbH
Hall A
|
LUNCH BREAK, EXHIBITION
& POSTERS
|
| Short
Break |
15:00
- 19:00
Registration Opens |
|
14:30-16:30
|
|
15:00-17:00
AD, PD, MCI, VD: Clinical, Epidemiological and
Pharmacoeconomical
Aspects
Hall A
|
Cholinesterase
AChE Inhibition:
Basic &
Therapeutic
Aspects
Hall A
|
AD:
Neurotoxicity
Amyloid, TAU
Hall B
|
Cholesterol &
Amyloid Modulation
Hall A
|
Diagnostic
and Genetic
Aspects of AD
and PD (II)
Hall B
|
DIADEM
Symposium:
Early Diagnosis
of AD
& Related Dementia
Hall A
|
Oxidative Stress
in AD, PD, LBD
Hall A
|
Acetycholin-esterase (II): Treatments
in AD, PD and
other Related Disorders
Hall B
|
|
16:30-17:00
|
|
17:00-17:30
COFFEE BREAK
|
COFFEE
BREAK, EXHIBITION & POSTERS |
|
17:00-19:00
|
18:00-20:00
Registration Opens |
17:30-19:30
Neurogenetics of AD & PD; Genetic Basis for
Responsiveness to
Approved Drugs &
Pharmacogenomics
Hall A
|
Potential Disease
Modification in AD
(Alpha-,Beta-& Gamma-
Secretases and Prevention of
A-Beta Aggregation
Hall A
|
LBD: From
Molecular Genetics
to Animal Models
and Treatment
Strategies
Hall B
|
17:00-18:20
LBD, Triple Brain Amyloidosis
Hall A
|
Imaging in AD, PD,
MCI
Hall B
|
Animal Models
in AD, PD & LBD
(II)
Hall A
|
APP, Amyloids,
alpha, -beta- & gamma-
Secretases
Hall B
|
17:00 - 18:00
Closing session
Hall A
|
18:20-19:20
CAA,
Prion Disease
and Progressive
Supranuclear
Palsy
Hall A
|
|
19:30-20:30
|
|
Get
Together Reception |
|
|
|
|
|
|
| 20:30
|
|
|
|
|
21:00-22:30
Flamenco Night
|
21:00
Gala Cocktail and Tour (Optional) |
